Ventyx Biosciences, Inc. (VTYX) Misses Q2 EPS by 21c
Tweet
Share
E-mail
Get Alerts VTYX Hot Sheet
Join SI Premium – FREE
Ventyx Biosciences, Inc. (NASDAQ: VTYX) reported Q2 EPS of ($0.91), $0.21 worse than the analyst estimate of ($0.70).
For earnings history and earnings-related data on Ventyx Biosciences, Inc. (VTYX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Definitive Healthcare names Clay Ritchey as new CEO
- J.P. Morgan cuts NIO to Neutral, slashes price target on weak demand outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
